[ad_1]
The United States of America is preparing for the fall and has ordered more than 100 million doses of the vaccine against the corona virus from the companies Biontech and Pfizer.
Washington announced that an agreement has been reached to buy 105 million doses of vaccines at a price of 3.2 billion dollars.
The US government fears a new rise in the number of infections in the fall.
The order includes vaccines for both adults and children. The supply of vaccines against COVID-19 is scheduled to begin in late summer.
According to the head of Pfizer, Albert Bourla, it is about vaccines that can specifically protect against newer variants of the virus such as Omicron.
With the Covid vaccines, the company Biontech is working with its American partner Pfizer not only on a vaccine adapted to the highly contagious variant Omikron, which is expected to receive possible approval for use in the fall.
In the second half of the year the Mainz-based company also wants to start clinical testing of next-generation vaccines, which are expected to offer protection against a large number of corona viruses.
These include T-cell booster vaccines, which protect mainly against severe disease, and pan-coronavirus vaccines, which are designed to protect against the entire virus family and its mutations.
The goal is “to provide permanent protection against different variants”.
top channel
[ad_2]
Source link
